Investing
Naama Stauber Breckler, CEO and cofounder of Better Health, discusses the company's latest strategic funding round and how it plans to use the investment.
Also, a gastric cancer detection tool in India has received a breakthrough designation from the US FDA.
Dr. Guido Giunti discusses patient involvement and the necessity of being forward-thinking in creating digital therapeutics.
Cardiac and lung-disease platform Eko Health secured $41 million in Series D funding.
The investment comes less than a year after the company launched with $9 million in funding, bringing its total raise to more than $25 million.
The company will use the funds to expand its cloud-based automation platform for providers and pharmaceutical companies.
It is now set to take on the international markets three years after its inception.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.